Table 5.
Methods used in SRs and MAs to synthesize the available evidence from the primary studies.
| Methods | Reviews | n | |
| Qualitative methods (n=15) |
|
|
|
|
|
Reported outcomes | [30,32,35-37,40-43,45,49] | 11 |
|
|
Levels of evidence (study design) | [29,32,37,48] | 4a |
|
|
Vote counting (intervention effect) | [29] | 1a |
|
|
Telemonitoring modality | [26,33] | 2 |
| Meta-analytic methods (n=9) |
|
|
|
| Summary statistics |
|
|
|
|
|
Risk ratios (for dichotomous data) | [27,28,31,34] | 4 |
|
|
Risk difference (for dichotomous data) | [27] | 1b |
|
|
Mean difference (for continuous data) | [38,39,46] | 3 |
|
|
Standardized mean difference (for continuous data) | [44,47] | 2 |
| Heterogeneity |
|
|
|
|
|
Assessment of heterogeneity by means of a statistical test | [27,28,31,34,38,39,44,46,47] | 9 |
|
|
Reported Cochran’s Q statistic (Chi-square test) of heterogeneity | [27,28,31,44,46,47] | 6 |
|
|
Reported I2 test of heterogeneity | [27,28,31,34,38,39,46,47] | 8 |
| Statistical model |
|
|
|
|
|
Random effects meta-analysis | [27,34,38,47] | 4 |
|
|
Fixed effect meta-analysis | [28,31,44] | 3 |
| Meta-analysis diagnostics |
|
|
|
|
|
Subgroup analysis | [34,46,47] | 3 |
|
|
Sensitivity analysis | [31,38] | 2 |
aIncludes reviews that used two different methods.
bSame review that used two different summary statistics.